• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自体骨髓源细胞移植治疗系统性硬化症患者的治疗性血管生成。

Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells.

机构信息

Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan.

出版信息

Mod Rheumatol. 2010 Jun;20(3):263-72. doi: 10.1007/s10165-010-0274-x. Epub 2010 Feb 19.

DOI:10.1007/s10165-010-0274-x
PMID:20169390
Abstract

We examined the efficacy and safety of autologous transplantation of bone-marrow-derived cells in patients with intractable ulcers caused by systemic sclerosis. Eight patients with ulcers resistant to treatment were enrolled. Bone marrow cells were gathered from the bilateral iliac crests with multiple repositioning bone marrow needles, and bone-marrow-derived mononuclear cells were isolated and injected into skeletal muscles of the ischemic limb. Visual analog scale (VAS), Sclerosis Health Assessment Questionnaire (SHAQ), modified Rodnan total skin score (mTSS), and the size and depth of the ulcer were examined. Thermography, capillaroscopy, intra-arterial digital subtraction angiography (IA-DSA), and laser Doppler flowmetry were also examined before and after transplantation. In all patients, reduction of ulcer size and improvement of VAS were observed after treatment. Elevation of surface temperature, increase of blood flow volume, and new capillaries of the nail bed were also found after our treatment. There were no major adverse effects of this treatment. Autologous transplantation of bone-marrow-derived cells was shown to be a novel and useful approach to intractable ulcers in systemic sclerosis.

摘要

我们研究了自体骨髓细胞移植治疗系统性硬化症所致难治性溃疡的疗效和安全性。共纳入 8 例溃疡治疗抵抗的患者。采用多部位定位骨髓穿刺针从双侧髂嵴采集骨髓细胞,分离骨髓源性单个核细胞并注射到缺血肢体的骨骼肌中。使用视觉模拟评分(VAS)、硬皮病健康评估问卷(SHAQ)、改良 Rodnan 总皮肤评分(mTSS)和溃疡的大小和深度进行评估。在移植前后还进行了热成像、毛细血管镜、动脉内数字减影血管造影(IA-DSA)和激光多普勒血流仪检查。所有患者治疗后溃疡面积缩小,VAS 改善。我们的治疗还发现了表面温度升高、血流体积增加和甲床新毛细血管。该治疗无重大不良反应。自体骨髓细胞移植是治疗系统性硬化症难治性溃疡的一种新颖而有用的方法。

相似文献

1
Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells.自体骨髓源细胞移植治疗系统性硬化症患者的治疗性血管生成。
Mod Rheumatol. 2010 Jun;20(3):263-72. doi: 10.1007/s10165-010-0274-x. Epub 2010 Feb 19.
2
Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis.自体祖细胞植入作为系统性硬化症中缺血性手指的一种新型治疗干预措施。
Rheumatology (Oxford). 2009 Jan;48(1):61-4. doi: 10.1093/rheumatology/ken407. Epub 2008 Nov 20.
3
Therapeutic vascular angiogenesis for intractable macroangiopathy-related digital ulcer in patients with systemic sclerosis: a pilot study.治疗性血管生成治疗系统性硬化症相关难治性大血管病变性指端溃疡:一项初步研究。
Rheumatology (Oxford). 2014 May;53(5):854-9. doi: 10.1093/rheumatology/ket432. Epub 2014 Jan 3.
4
[Clinical and capillaroscopic regression of CD30 anaplastic lymphoma associated with limited cutaneous systemic sclerosis following autologous bone marrow transplantation].[自体骨髓移植后与局限性皮肤系统性硬化症相关的CD30间变性淋巴瘤的临床及毛细血管镜下消退情况]
Ann Dermatol Venereol. 2014 Jun-Jul;141(6-7):446-51. doi: 10.1016/j.annder.2014.04.116. Epub 2014 Jun 2.
5
Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.他汀类药物:可能对系统性硬化症相关的雷诺现象和指端溃疡的治疗有用。
J Rheumatol. 2008 Sep;35(9):1801-8. Epub 2008 Aug 15.
6
[A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].骨髓刺激后自体骨髓单个核细胞植入治疗下肢缺血的临床研究
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006 Oct;20(10):1017-20.
7
Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.骨髓单个核细胞(MNCs)和外周血单个核细胞的治疗性血管生成:用于缺血后肢的移植
Ann Vasc Surg. 2008 Mar;22(2):238-47. doi: 10.1016/j.avsg.2007.07.037. Epub 2008 Feb 20.
8
Therapeutic angiogenesis by autologous bone marrow cell implantation together with allogeneic cultured dermal substitute for intractable ulcers in critical limb ischaemia.自体骨髓细胞移植联合异体培养的真皮替代物治疗难治性肢体缺血性溃疡的血管生成。
J Plast Reconstr Aesthet Surg. 2010 Nov;63(11):1875-82. doi: 10.1016/j.bjps.2009.11.037. Epub 2010 Jan 8.
9
Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans.血栓闭塞性脉管炎患者自体骨髓单个核细胞移植的非盲法初步研究。
Circulation. 2006 Dec 12;114(24):2679-84. doi: 10.1161/CIRCULATIONAHA.106.644203. Epub 2006 Dec 4.
10
Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.通过自体骨髓单个核细胞移植对重症肢体缺血的血栓闭塞性脉管炎(伯格氏病)患者进行治疗性血管生成。
J Vasc Surg. 2008 Dec;48(6 Suppl):53S-60S; discussion 60S. doi: 10.1016/j.jvs.2008.09.005.

引用本文的文献

1
Mesenchymal Stem-Cell-Derived Exosomes and MicroRNAs: Advancing Cell-Free Therapy in Systemic Sclerosis.间充质干细胞衍生的外泌体与微小RNA:推动系统性硬化症的无细胞治疗
Cells. 2025 Jul 3;14(13):1018. doi: 10.3390/cells14131018.
2
Stem cell therapy in systemic sclerosis.系统性硬化症中的干细胞疗法。
Clin Rheumatol. 2025 Jul 2. doi: 10.1007/s10067-025-07557-y.
3
Research progress on mesenchymal stem cells and their exosomes in systemic sclerosis.间充质干细胞及其外泌体在系统性硬化症中的研究进展
Front Pharmacol. 2023 Aug 25;14:1263839. doi: 10.3389/fphar.2023.1263839. eCollection 2023.
4
Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches.系统性硬化症的细胞治疗:从造血干细胞移植到创新方法。
Cells. 2022 Oct 24;11(21):3346. doi: 10.3390/cells11213346.
5
Recent Advances in Cell Therapeutics for Systemic Autoimmune Diseases.系统性自身免疫性疾病细胞治疗的最新进展
Immune Netw. 2022 Feb 11;22(1):e10. doi: 10.4110/in.2022.22.e10. eCollection 2022 Feb.
6
Current State and Issues of Regenerative Medicine for Rheumatic Diseases.风湿病再生医学的现状与问题
Front Med (Lausanne). 2022 Jan 28;9:813952. doi: 10.3389/fmed.2022.813952. eCollection 2022.
7
Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis.联合全身和局部应用细胞疗法治疗系统性硬化症。
Bone Marrow Transplant. 2022 Jan;57(1):17-22. doi: 10.1038/s41409-021-01492-7. Epub 2021 Oct 18.
8
Locoregional Treatments for Digital Ulcers in Systemic Sclerosis: A Systematic Review.系统性硬化症中手指溃疡的局部区域治疗:一项系统评价
Acta Derm Venereol. 2021 Jun 22;101(6):adv00478. doi: 10.2340/00015555-3839.
9
A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol.一项评估异基因间充质基质细胞肌肉注射治疗系统性硬化症指端溃疡安全性的随机安慰剂对照双盲试验:MANUS试验方案。
BMJ Open. 2018 Aug 20;8(8):e020479. doi: 10.1136/bmjopen-2017-020479.
10
Maggot debridement therapy with a direct dressing can cause compression injuries in patients with chronic limb ischemia.直接包扎的蛆虫清创疗法可能会导致慢性肢体缺血患者出现压迫性损伤。
Case Reports Plast Surg Hand Surg. 2017 Sep 4;4(1):84-88. doi: 10.1080/23320885.2017.1373596. eCollection 2017.